LNTH
Lantheus Holdings Inc
NASDAQ: LNTH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$81.17
-2.85% today
Updated 2026-04-29
Market cap
$5.28B
P/E ratio
23.80
P/S ratio
3.43x
EPS (TTM)
$3.41
Dividend yield
—
52W range
$47 – $109
Volume
1.0M
Lantheus Holdings Inc (LNTH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $356.29M | $288.11M | $283.67M | $301.60M | $293.46M | $301.85M | $331.38M | $343.37M | $347.34M | $339.41M | $425.21M | $935.06M | $1.30B | $1.53B | $1.54B |
| Revenue growth (YoY) | — | -19.1% | -1.5% | +6.3% | -2.7% | +2.9% | +9.8% | +3.6% | +1.2% | -2.3% | +25.3% | +119.9% | +38.6% | +18.3% | +0.5% |
| Cost of revenue | $261.08M | $212.91M | $206.31M | $176.08M | $157.94M | $164.07M | $169.24M | $168.49M | $172.53M | $200.65M | $237.51M | $353.36M | $586.89M | $545.62M | $599.66M |
| Gross profit | $95.22M | $75.20M | $77.36M | $125.52M | $135.52M | $137.78M | $162.13M | $174.88M | $174.81M | $138.76M | $187.69M | $581.70M | $709.54M | $988.29M | $941.95M |
| Gross margin | 26.7% | 26.1% | 27.3% | 41.6% | 46.2% | 45.6% | 48.9% | 50.9% | 50.3% | 40.9% | 44.1% | 62.2% | 54.7% | 64.4% | 61.1% |
| R&D | $40.95M | $40.60M | $30.46M | $13.67M | $14.36M | $12.20M | $18.13M | $17.07M | $20.02M | $32.79M | $44.97M | $311.68M | $77.71M | $168.10M | $177.31M |
| SG&A | $32.86M | $32.52M | $33.04M | $37.31M | $43.89M | $38.83M | $49.84M | $50.17M | $61.24M | $69.27M | $150.40M | $133.58M | $125.46M | $193.69M | $275.12M |
| Operating income | $-17.28M | $-750000.00 | $-18.89M | $39.42M | $42.53M | $56.59M | $51.85M | $64.49M | $51.66M | $-4.20M | $-60.83M | $36.20M | $364.64M | $456.98M | $310.83M |
| Operating margin | -4.8% | -0.3% | -6.7% | 13.1% | 14.5% | 18.7% | 15.6% | 18.8% | 14.9% | -1.2% | -14.3% | 3.9% | 28.1% | 29.8% | 20.2% |
| EBITDA | $17.74M | $26.86M | $7.53M | $58.17M | $46.59M | $73.17M | $77.19M | $80.81M | $55.62M | $22.69M | $-25.00M | $81.83M | $491.00M | $515.27M | $403.64M |
| EBITDA margin | 5.0% | 9.3% | 2.7% | 19.3% | 15.9% | 24.2% | 23.3% | 23.5% | 16.0% | 6.7% | -5.9% | 8.8% | 37.9% | 33.6% | 26.2% |
| EBIT | $-15.02M | $-542000.00 | $-17.63M | $39.92M | $26.94M | $54.91M | $58.05M | $66.95M | $42.24M | $-2.00M | $-67.29M | $33.90M | $430.96M | $450.65M | $333.54M |
| Interest expense | $37.66M | $42.01M | $42.91M | $42.29M | $38.72M | $26.62M | $18.41M | $17.41M | $13.62M | $9.48M | $7.75M | $7.18M | $20.02M | $19.67M | $19.75M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-137.26M | $-42.00M | $-61.55M | $-3.56M | $-14.75M | $26.76M | $123.39M | $40.52M | $31.67M | $-13.47M | $-71.28M | $28.07M | $326.66M | $312.44M | $233.56M |
| Net income growth (YoY) | — | +69.4% | -46.6% | +94.2% | -314.1% | +281.5% | +361.0% | -67.2% | -21.8% | -142.5% | -429.1% | +139.4% | +1063.9% | -4.4% | -25.2% |
| Profit margin | -38.5% | -14.6% | -21.7% | -1.2% | -5.0% | 8.9% | 37.2% | 11.8% | 9.1% | -4.0% | -16.8% | 3.0% | 25.2% | 20.4% | 15.2% |